CLVT Stock Summary and Trading Ideas (Clarivate PLC | NYSE:CLVT)

Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.

Clarivate PLC trades on the NYSE stock market under the symbol CLVT.

As of March 18, 2026, CLVT stock price declined to $2.53 with 4,266,242 million shares trading.

CLVT has a beta of 1.51, meaning it tends to be more sensitive to market movements. CLVT has a correlation of 0.16 to the broad based SPY ETF.

CLVT has a market cap of $1.67 billion. This is considered a Small Cap stock.

Last quarter Clarivate PLC reported $617 million in Revenue and $.20 earnings per share. This beat revenue expectation by $13 million and exceeded earnings estimates by $.05.

In the last 3 years, CLVT traded as high as $10.03 and as low as $1.66.

The top ETF exchange traded funds that CLVT belongs to (by Net Assets): AVUV, FXL, VXF, DFAT, DFSV.

CLVT has underperformed the market in the last year with a return of -41.3%, while the SPY ETF gained +19.2%. In the last 3 month period, CLVT fell short of the market, returning -26.2%, while SPY returned -1.6%. However, in the most recent 2 weeks CLVT has outperformed the stock market by returning +0.4%, while SPY returned -3.5%.

CLVT support price is $2.42 and resistance is $2.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLVT shares will trade within this expected range on the day.